Dolutegravir / Lamivudine is named as a drug or biological intervention in 2 clinical trials in our USA and China trial registers, 2 of which are recruiting. Lead sponsors include ViiV Healthcare (1) and Affiliated Hospital of Nantong University (1). Registered phases: Phase 2 and Observational. Conditions studied include HIV Infections; HIV Infection.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07202546 | A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) (ClinicalTrials.gov ↗) HIV Infections |
Phase 2 | Recruiting |
| NCT06619288 | Good-first: B/F/TAF As First-line ART (ClinicalTrials.gov ↗) HIV Infection |
Observational | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| HIV Infections | 1 |
| HIV Infection | 1 |
| Lead sponsor | Trials |
|---|---|
| ViiV Healthcare | 1 |
| Affiliated Hospital of Nantong University | 1 |
| Register | Dolutegravir / Lamivudine trials |
|---|---|
| Clinical trials in USA | 1 |
| Clinical trials in China | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Dolutegravir / Lamivudine works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Dolutegravir / Lamivudine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.